UPDATE 1-GlaxoSmithKline breathes easier as U.S. approves triple lung drug By: Reuters: Company News September 19, 2017 at 04:02 AM EDT * CEO sees it as one of three "critical" new drug launches (Adds detail on competition, analyst reaction, shares) Read More >> Related Stocks: Astrazeneca Plc ADR Gsk Plc ADR Innoviva Inc Novan Inc